CSL Limited
CSL
株式のランク
#362
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
株価
$138.58
時価総額
$66.50B
変化（1日）
0.72%
変化（1年）
-2.29%
国
AU
取引 CSL Limited (CSL)
カテゴリー
Healthcare
CSL Limited（CSL）の配当利回りの履歴
CSL Limited（銘柄コード: CSL）の配当利回り（TTM）は2024-06-30時点で1.35%です。
過去5年間の平均配当利回り: 1.54%
過去5年間の平均配当利回り: 1.54%
CSL Limited（CSL）の2000から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 2.17% | 15.43% |
| 2025 | 1.88% | 39.26% |
| 2024 | 1.35% | -25.41% |
| 2023 | 1.81% | 9.70% |
| 2022 | 1.65% | 66.67% |
| 2021 | 0.99% | 41.43% |
| 2020 | 0.70% | -39.13% |
| 2019 | 1.15% | 16.16% |
| 2018 | 0.99% | 2.06% |
| 2017 | 0.97% | -37.01% |
| 2016 | 1.54% | 18.46% |
| 2015 | 1.30% | -14.47% |
| 2014 | 1.52% | -7.88% |
| 2013 | 1.65% | -21.05% |
| 2012 | 2.09% | -19.62% |
| 2011 | 2.60% | 31.31% |
| 2010 | 1.98% | 47.76% |
| 2009 | 1.34% | 26.42% |
| 2008 | 1.06% | 23.26% |
| 2007 | 0.86% | -8.51% |
| 2006 | 0.94% | 28.77% |
| 2005 | 0.73% | 65.91% |
| 2004 | 0.44% | -76.84% |
| 2003 | 1.90% | 533.33% |
| 2002 | 0.30% | 15.38% |
| 2001 | 0.26% | -35.00% |
| 2000 | 0.40% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
|
| 0.72% |
BE
|
